At 7 million expenditure per 1/4 there is only ~35 million cash left ~today with expenditure significantly rising going into human trials. Coupled with more market listings (including Europe that has no risk appetitie), and with payouts for closure of Dubai and employees jumping ship.
With ~35 million in the bank and revenue ~3 years out (2015 at best pending success at all hurdles) how can you remotely argue against PRR not being fundamentally underpinned?
Is there a reputable independent broker forecast for PRR?
Also, I never called this company Prima Bio-Dead so get your facts straight.
At 7 million expenditure per 1/4 there is only ~35 million cash...
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.020(6.67%) |
Mkt cap ! $464.8M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 32.3¢ | 30.0¢ | $1.040M | 3.328M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 42705 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |